TW200400951A - Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and use in medicaments - Google Patents
Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and use in medicaments Download PDFInfo
- Publication number
- TW200400951A TW200400951A TW092103969A TW92103969A TW200400951A TW 200400951 A TW200400951 A TW 200400951A TW 092103969 A TW092103969 A TW 092103969A TW 92103969 A TW92103969 A TW 92103969A TW 200400951 A TW200400951 A TW 200400951A
- Authority
- TW
- Taiwan
- Prior art keywords
- formula
- group
- phenyl
- alkyl
- oxygen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10208987A DE10208987A1 (de) | 2002-02-28 | 2002-02-28 | Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200400951A true TW200400951A (en) | 2004-01-16 |
Family
ID=27740558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092103969A TW200400951A (en) | 2002-02-28 | 2003-02-26 | Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and use in medicaments |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1480960B1 (enExample) |
| JP (1) | JP4486363B2 (enExample) |
| KR (1) | KR20040095240A (enExample) |
| CN (1) | CN1639137A (enExample) |
| AR (1) | AR038701A1 (enExample) |
| AT (1) | ATE557012T1 (enExample) |
| AU (1) | AU2003226977A1 (enExample) |
| BR (1) | BR0307921A (enExample) |
| CA (1) | CA2477031A1 (enExample) |
| CO (1) | CO5611146A2 (enExample) |
| DE (1) | DE10208987A1 (enExample) |
| HR (1) | HRP20040782A2 (enExample) |
| HU (1) | HUP0402671A3 (enExample) |
| IL (1) | IL163683A0 (enExample) |
| MA (1) | MA27172A1 (enExample) |
| MX (1) | MXPA04007960A (enExample) |
| NO (1) | NO20044090L (enExample) |
| PE (1) | PE20030928A1 (enExample) |
| PL (1) | PL370423A1 (enExample) |
| RU (1) | RU2004128933A (enExample) |
| TW (1) | TW200400951A (enExample) |
| WO (1) | WO2003072555A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7074822B2 (en) | 2004-02-23 | 2006-07-11 | Solvay Pharmaceuticals Gmbh | Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them |
| WO2006045799A2 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| CA2710743A1 (en) * | 2007-12-27 | 2009-07-09 | Bial-Portela & Ca., S.A. | 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| WO2010074587A2 (en) | 2008-12-23 | 2010-07-01 | Bial - Portela & Ca., S.A. | 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19942354A1 (de) * | 1999-09-04 | 2001-03-08 | Aventis Pharma Gmbh | Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln |
| SK12752002A3 (sk) * | 2000-03-07 | 2003-04-01 | Aventis Pharma Deutschland Gmbh | Substituované 3-fenyl-5-alkoxy-1,3,4-oxdiazol-2-óny, spôsob ich prípravy a ich použitie ako liečivo na inhibovanie hormónsenzitívnej lipázy |
-
2002
- 2002-02-28 DE DE10208987A patent/DE10208987A1/de not_active Withdrawn
-
2003
- 2003-02-05 PE PE2003000134A patent/PE20030928A1/es not_active Application Discontinuation
- 2003-02-14 AT AT03742936T patent/ATE557012T1/de active
- 2003-02-14 HU HU0402671A patent/HUP0402671A3/hu unknown
- 2003-02-14 BR BR0307921-0A patent/BR0307921A/pt not_active Application Discontinuation
- 2003-02-14 CA CA002477031A patent/CA2477031A1/en not_active Abandoned
- 2003-02-14 HR HR20040782A patent/HRP20040782A2/hr not_active Application Discontinuation
- 2003-02-14 AU AU2003226977A patent/AU2003226977A1/en not_active Abandoned
- 2003-02-14 WO PCT/EP2003/001484 patent/WO2003072555A1/de not_active Ceased
- 2003-02-14 CN CNA038047837A patent/CN1639137A/zh active Pending
- 2003-02-14 IL IL16368303A patent/IL163683A0/xx unknown
- 2003-02-14 RU RU2004128933/04A patent/RU2004128933A/ru not_active Application Discontinuation
- 2003-02-14 EP EP03742936A patent/EP1480960B1/de not_active Expired - Lifetime
- 2003-02-14 PL PL03370423A patent/PL370423A1/xx not_active Application Discontinuation
- 2003-02-14 KR KR10-2004-7013485A patent/KR20040095240A/ko not_active Withdrawn
- 2003-02-14 MX MXPA04007960A patent/MXPA04007960A/es unknown
- 2003-02-14 JP JP2003571261A patent/JP4486363B2/ja not_active Expired - Fee Related
- 2003-02-26 AR ARP030100624A patent/AR038701A1/es unknown
- 2003-02-26 TW TW092103969A patent/TW200400951A/zh unknown
-
2004
- 2004-07-27 MA MA27803A patent/MA27172A1/fr unknown
- 2004-08-26 CO CO04083779A patent/CO5611146A2/es not_active Application Discontinuation
- 2004-09-27 NO NO20044090A patent/NO20044090L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20040782A2 (en) | 2005-02-28 |
| HUP0402671A3 (en) | 2006-07-28 |
| JP2005519085A (ja) | 2005-06-30 |
| AU2003226977A1 (en) | 2003-09-09 |
| CA2477031A1 (en) | 2003-09-04 |
| PL370423A1 (en) | 2005-05-30 |
| EP1480960A1 (de) | 2004-12-01 |
| AR038701A1 (es) | 2005-01-26 |
| NO20044090L (no) | 2004-11-04 |
| JP4486363B2 (ja) | 2010-06-23 |
| EP1480960B1 (de) | 2012-05-09 |
| CO5611146A2 (es) | 2006-02-28 |
| KR20040095240A (ko) | 2004-11-12 |
| IL163683A0 (en) | 2005-12-18 |
| MA27172A1 (fr) | 2005-01-03 |
| PE20030928A1 (es) | 2003-12-17 |
| DE10208987A1 (de) | 2003-09-11 |
| MXPA04007960A (es) | 2004-11-26 |
| HUP0402671A2 (hu) | 2005-04-28 |
| ATE557012T1 (de) | 2012-05-15 |
| WO2003072555A1 (de) | 2003-09-04 |
| RU2004128933A (ru) | 2005-04-20 |
| BR0307921A (pt) | 2004-12-21 |
| CN1639137A (zh) | 2005-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9018258B2 (en) | Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof | |
| US9776997B2 (en) | 3-aryl-substituted imidazo[1,2-A]pyridines and their use | |
| JP3295143B2 (ja) | ベンズアニリド誘導体 | |
| US9266885B2 (en) | Substituted 5-fluoro-1H-pyrazolopyridines and their use | |
| EP2410857B1 (en) | P2x3, receptor antagonists for treatment of pain | |
| JP5911950B2 (ja) | 分枝状３−フェニルプロピオン酸誘導体およびそれらの使用 | |
| CN104703964B (zh) | 取代氨基茚满‑和氨基萘满甲酸及其用途 | |
| US7807684B2 (en) | HIV reverse transcriptase inhibitors | |
| US9771360B2 (en) | Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use | |
| KR20130140868A (ko) | 항세균제로서 유용한 이속사졸 유도체 | |
| RS55651B1 (sr) | Nove 5-aminotetrahidrohinolin-2-karbonske kiseline i njihova upotreba | |
| HU202505B (en) | Process for producing leucotrinen-antagonistic nitriles and tetrazoles | |
| US20140128425A1 (en) | Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use | |
| JP2009514837A (ja) | グルコキナーゼ調節物質としてのトリシクロ置換アミド | |
| JP2013510883A (ja) | スフィンゴシン−１−リン酸受容体変調因子および不斉合成方法 | |
| JP2013532657A (ja) | 環式ｎ，ｎ’−ジアリールチオ尿素及びｎ，ｎ’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用 | |
| US20160176880A1 (en) | Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereof | |
| US20170050962A1 (en) | Imidazo[1,2-a]pyridines as stimulators of soluble guanylate cyclase for treating cardiovascular diseases | |
| CA3022102A1 (en) | Benzoylglycine derivatives and methods of making and using same | |
| WO2009025820A2 (en) | Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution | |
| WO2012010577A1 (de) | Substituierte oxazolidinone und oxazinanone und ihre verwendung | |
| TW200400951A (en) | Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and use in medicaments | |
| US20170101407A1 (en) | 6-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators | |
| US20170057958A1 (en) | Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases | |
| US10150773B2 (en) | N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases |